Home » Topics » Ocular, BioWorld Science

Ocular, BioWorld Science
RSS

Targeting tenascin-C could reduce the effects of retinal ischemia

June 2, 2021

Preclinical results presented for a gene therapy to treat CDHR1-related retinopathy

May 27, 2021

New PARP-1 inhibitors described by Kukje Pharma, Chungnam National University

May 26, 2021

NCX-667 demonstrates IOP-lowering ability in a number of animal models

May 26, 2021

KIF13B linked to progression of wet age-related macular degeneration

May 21, 2021

PYC reports efficacy data from ADOA program in patient cell models

May 18, 2021

Unity opens enrollment in phase IIa study of UBX-1325 in DME

May 18, 2021

THCVHS shows superior IOP-lowering activity compared to glaucoma standard of care in vivo

May 18, 2021

Platelet complement and innate immune system proteins elevated in age-related macular degeneration

May 18, 2021

FN-EDA transgenic mice developed as a new model of glaucoma

May 18, 2021

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan. 28, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for January 28, 2025
New drugs with the same old resistance tricks?
BioWorld
According to the World Health Organization (WHO), multidrug-resistant pathogens caused over 1.27 million deaths worldwide in 2020. And figures are rising, with...
OS Therapies heading to FDA with positive osteosarcoma data
BioWorld
With positive data in hand from its phase IIb trial testing immunotherapy candidate OST-HER2 in osteosarcoma, OS Therapies Inc. anticipates a regulatory filing...
Vilastobart set apart? Xilio phase II combo performs in CRC
BioWorld
“The [colorectal cancer field is moving, and thankfully it’s moving quickly,” said Marwan Fakih, gastrointestinal specialist at City of Hope, speaking about...